1177 — Sino Biopharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$85.67bn
- HK$90.92bn
- CNY31.83bn
Mainland China stocks close lower ahead of long holiday, Hong Kong books best month since Jan 2023
Hong Kong shares jump on policy support; China slips
Brief: Sino Biopharmaceutical Posts FY Profit Attributable RMB2.33 Billion
Brief: Sino Biopharmaceutical Says Approval For Marketing Of Iopromide Injection
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
Brief: Sino Biopharmaceutical Says Disposal Of Equity Interest In Cp Qingdao
Brief: Sino Biopharmaceutical Says Application For Market Launch Of "Obeticholic Acid Tablets" Accepted By NMPA
Brief: Sino Biopharmaceutical Says Purchased Aggregate Of 78.4 Million Shares Under Share Purchase Plan
Brief: Sino Biopharmaceutical Says TRD205 Tablet Approved By NMPA Of China
China's Sino Biopharmaceutical up on products' inclusion in National Drug Catalogue
Brief: Sino Biopharmaceutical Says Application For Marketing Of TQG203 Accepted By China's NMPA
Brief: Sino Biopharmaceutical Says Voluntary Announcement Approval Of Clinical Trial For TQB3015
Brief: Sino Biopharmaceutical Disposes Of 55% Equity Interest In Suzhou Tianqing Xingwei Medicines
Sino Biopharma hits near 3-month peak on drug's clinical trial approval
Brief: Sino Biopharmaceutical Says Tqg3902 Angiotensin II Injection Approved For Clinical Trial
Brief: Sino Biopharmaceutical Says Application For Phase Ib/Ii Clinical Trial Of Innovative Drug Accepted
Brief: Sino Biopharmaceutical Announces Disposal Of Equity Interest In Ct Tongyong
Brief: Sino Biopharmaceutical Says IND Application Of TRD205 (AT2R Antagonist) Accepted By FDA
Brief: Sino Biopharmaceutical Reports HY Profit Attributable RMB1.26 BLN